Rituximab Therapy in a Patient with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia Associated with Chronic Lymphocytic Leukemia
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.
Tandra P, Krishnamurthy J, Bhatt V, Newman K, Armitage J, Akhtari M Mediterr J Hematol Infect Dis. 2013; 5(1):e2013068.
PMID: 24363883 PMC: 3867225. DOI: 10.4084/MJHID.2013.068.
References
1.
Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S
. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia. 2002; 16(10):2092-5.
DOI: 10.1038/sj.leu.2402676.
View
2.
Leach M, Parsons R, Reilly J, Winfield D
. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders. Clin Lab Haematol. 2000; 22(3):175-8.
DOI: 10.1046/j.1365-2257.2000.00305.x.
View
3.
Fernandez M, Llopis I, Pastor E, Real E, Grau E
. Immune thrombocytopenia induced by fludarabine successfully treated with rituximab. Haematologica. 2003; 88(2):ELT02.
View
4.
Okamoto M, Nakano S, Namura K, Yamada N, Uchida R, Fuchida S
. CD5-negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab. Am J Hematol. 2004; 77(4):413-5.
DOI: 10.1002/ajh.20223.
View
5.
Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A
. B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica. 2003; 88(5):538-46.
View